Phapros Tbk PT
IDX:PEHA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
264
364
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| ID |
|
Phapros Tbk PT
IDX:PEHA
|
258.7B IDR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
972.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.3B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
93.8B EUR |
Loading...
|
Market Distribution
| Min | -111 644.7% |
| 30th Percentile | 0% |
| Median | 6.1% |
| 70th Percentile | 12.9% |
| Max | 524 864.9% |
Other Profitability Ratios
Phapros Tbk PT
Glance View
PT Phapros Tbk is a pharmaceutical company, which engages in the production and marketing of pharmaceutical products. The company is headquartered in Jakarta Selatan, Dki Jakarta and currently employs 1,485 full-time employees. The company went IPO on 2018-12-26. The firm's medical devices include ACS MB system, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho and NPC-STRIP G. Its branded drugs include Colkatriol 0.25 mcg 30 Cap, DEXTROFEN S SYRUP 60ml, Diafac XR, Diafac 500 mg 10 tablets, Dextamine Syrup 60 ml, Diapros Tablet, Proinfarction, Pehavask 5 & 10, Spirolactone 25 & 100, Dios, anemone, Pladel, and others. The firm also operates calibration laboratory. The company offers medicines for cardiovascular & hematopoietic, gastrointestinal & hepatobiliary, hormone Genito, urinary endocrine & metabolic, vitamins & minerals nutrition, dermatology, local anesthesia, immune & allergy, and others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Phapros Tbk PT is -12.9%, which is below its 3-year median of -4.3%.
Over the last 3 years, Phapros Tbk PT’s Operating Margin has decreased from 7.4% to -12.9%. During this period, it reached a low of -27.6% on Dec 31, 2024 and a high of 8.2% on Mar 31, 2023.